University of Vermont

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1791-01-01

Employees: 51

Market Cap: -

Website: http://www.uvm.edu

Clinical Trials

Mobile Phone-Based Motivational Interviewing in Kenya

Not Applicable

Completed

Conditions: Alcohol Use Disorder

Interventions: Behavioral: In-Person Motivational Interviewing (MI)
Behavioral: Mobile Motivational Interviewing (MI)

First Posted Date: 2018-06-29

Last Posted Date: 2018-06-29

Lead Sponsor: University of Vermont

Target Recruit Count: 322

Registration Number: NCT03573167

Piloting Visual Chat in Internet Obesity Treatment

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Behavioral Weight Loss + Text
Behavioral: Behavioral Weight Loss + Video

First Posted Date: 2018-04-09

Last Posted Date: 2018-12-06

Lead Sponsor: University of Vermont

Target Recruit Count: 32

Registration Number: NCT03491293

Locations: 🇺🇸
University of South Carolina, Columbia, South Carolina, United States
🇺🇸
Behavioral Weight Management Program/Univ of Vermont, Burlington, Vermont, United States

Performance Assessment of the PMD-200 Under General Anesthesia

Completed

Conditions: Pain
Intraoperative Complications
Opioid Use

Interventions: Device: NoL Index

First Posted Date: 2018-03-15

Last Posted Date: 2019-04-17

Lead Sponsor: University of Vermont

Target Recruit Count: 61

Registration Number: NCT03467230

Locations: 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States

Women in Cardiac Rehabilitation: Optimizing the Training Response

Not Applicable

Conditions: Women
Cardiac Rehabilitation
Coronary Artery Disease
Exercise Training

Interventions: Behavioral: Exercise training

First Posted Date: 2018-02-20

Last Posted Date: 2018-02-20

Lead Sponsor: University of Vermont

Target Recruit Count: 40

Registration Number: NCT03438968

Locations: 🇺🇸
University of Vermont College of Medicine, Burlington, Vermont, United States

Mobile Technology to Support Physical Therapy Exercise

Not Applicable

Completed

Conditions: Osteoarthritis of Knee
Osteoarthritis Of Hip

Interventions: Device: Mobile Application

First Posted Date: 2018-02-12

Last Posted Date: 2021-09-28

Lead Sponsor: University of Vermont

Target Recruit Count: 60

Registration Number: NCT03428893

Locations: 🇺🇸
Dee Physical Therapy, South Burlington, Vermont, United States

Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

Phase 2

Conditions: Opioid-use Disorder

Interventions: Drug: Buprenorphine/naloxone sublingual tablets

First Posted Date: 2018-02-05

Last Posted Date: 2019-05-03

Lead Sponsor: University of Vermont

Target Recruit Count: 100

Registration Number: NCT03420313

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

The Nicotinic Cholinergic System and Cognitive Aging

Phase 1

Completed

Conditions: Healthy Aging

Interventions: Drug: Nicotine patch, oral mecamylamine, placebo

First Posted Date: 2018-01-24

Last Posted Date: 2023-05-09

Lead Sponsor: University of Vermont

Target Recruit Count: 104

Registration Number: NCT03408574

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

Online Mind/Body Program for Fertility

Not Applicable

Completed

Conditions: Infertility

Interventions: Behavioral: Online Mind/Body Program for Fertility

First Posted Date: 2017-11-17

Last Posted Date: 2017-11-17

Lead Sponsor: University of Vermont

Target Recruit Count: 71

Registration Number: NCT03343405

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

Switching to Very Low Nicotine Content Cigarettes vs Reducing Cigarettes Per Day

Phase 2

Completed

Conditions: Tobacco Use Disorder

Interventions: Other: Very low nicotine content (VLNC) cigarettes and nicotine replacement therapy (NRT)
Other: Reduce cigarettes per day (CPD) with nicotine replacement therapy (NRT)

First Posted Date: 2017-02-23

Last Posted Date: 2022-10-04

Lead Sponsor: University of Vermont

Target Recruit Count: 74

Registration Number: NCT03060083

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States

Addition of Clonidine to Ropivacaine in Adductor Canal Block

Phase 4

Conditions: Postoperative Pain

Interventions: Drug: Placebo
Drug: Clonidine
Drug: Ropivacaine
Drug: Dexamethasone
Drug: Epinephrine

First Posted Date: 2017-02-17

Last Posted Date: 2018-05-03

Lead Sponsor: University of Vermont

Target Recruit Count: 80

Registration Number: NCT03057015

Locations: 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy